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AbstrAct
Background Quality improvement (QI) involves the use 
of systematic tools and methods to improve the quality of 
care and outcomes for patients. However, awareness and 
application of QI among healthcare professionals is poor and 
new strategies are needed to engage them in this area.
Objectives This study describes an innovative 
collaboration between one Higher Educational Institute 
(HEI) and Local Pharmaceutical Committees (LPCs) to 
develop a postgraduate QI module aimed to upskill 
community pharmacists in QI methods. The study explores 
pharmacist engagement with the learning and investigates 
the impact on their practice.
Methods Details of the HEI–LPCs collaboration and 
communication with pharmacist were recorded. Focus 
groups were held with community pharmacists who enrolled 
onto the module to explore their motivation for undertaking 
the learning, how their knowledge of QI had changed and 
how they applied this learning in practice. A constructivist 
qualitative methodology was used to analyse the data.
Results The study found that a HEI–LPC partnership was 
feasible in developing and delivering the QI module. Fifteen 
pharmacists enrolled and following its completion, eight 
took part in one of two focus groups. Pharmacists reported 
a desire to extend and acquire new skills. The HEI–LPC 
partnership signalled a vote of confidence that gave 
pharmacists reassurance to sign up for the training. Some 
found returning to academia challenging and reported 
a lack of time and organisational support. Despite this, 
pharmacists demonstrated an enhanced understanding 
of QI, were more analytical in their day- to- day problem- 
solving and viewed the learning as having a positive 
impact on their team’s organisational culture with potential 
to improve service quality for patients.
Conclusions With the increased adoption of new 
pharmacist’s roles and recent changes to governance 
associated with the COVID-19 pandemic, a HEI–LPC 
collaborative approach could upskill pharmacists and help 
them acquire skills to accommodate new working practices.
InTroducTIon
To alleviate the growing demands on the 
healthcare system and reduce pressure in 
general practice and secondary care settings, 
policy- makers and professional bodies have 
recognised the potential of community phar-
macists to adopt new roles and extended phar-
maceutical services.1 2 Examples of such roles 
include administration of vaccinations, smoking 
cessation services and medication reviews.3–5 
However, the adoption of new services often 
happens largely in the absence of additional 
pharmacist’s resource, organisational support, 
appropriate education and training and suit-
able means of remuneration.6 Research suggests 
community pharmacists generally perceive 
their workload to be increasingly contributing 
to work‐related stress and decreasing job satis-
faction.7 Concerns have been expressed about 
the quality and provision of community phar-
macy services. These include low public aware-
ness, expectations and uptake of extended 
services, perverse incentives leading to ‘gaming 
the system’ and under- developed pharmacist–
GP (General Practitioner) collaboration with 
consequential barriers to successful implemen-
tation and integration of pharmacy within the 
wider multidisciplinary team.8–10
One strategy to support clinical governance 
and enhance the quality and delivery of care 
is through the application of quality improve-
ment (QI). This approach forms part of the 
UK National Health Service (NHS) healthcare 
improvement strategy to promote safety, effec-
tiveness and patient experience.11 Despite an 
expectation that QI techniques should be an 
integral part of the culture of professional work, 
at present there only appears to be isolated 
examples of good practice.12 Within commu-
nity pharmacy QI strategies, its measurement 
and routine application in daily practice remain 
underdeveloped.13 It has been suggested that if 
QI systems and evidence- based tools are to be 
implemented in a sustainable fashion, support 
and funding for appropriate education and 
training should be made available in the science 
of safety and quality methods.14
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This research describes a new collaborative partner-
ship between a Higher Education Institute (HEI) and 
a cluster of Local Pharmaceutical Committees (LPCs). 
LPCs in England are responsible for designing, deliv-
ering and commissioning health services.15 LPCs have the 
potential to play a greater role in pharmacist continuing 
professional development (CPD) and thereby improve 
the quality of services delivered. There are approximately 
80 LPCs in England, each of which has a direct relation-
ship with pharmacy contractors, and to some extent, with 
pharmacists’ employees. The focus of the research was to 
describe an innovative HEI–LPC collaboration that co- de-
veloped a postgraduate QI module. This was designed to 
respond to calls for upskilling pharmacists in QI methods. 
It was anticipated that the enhancement of pharmacist’s 
knowledge of QI would, when effectively applied, facili-
tate positive practice change across a range of community 
pharmacy services. The paper also explores pharmacist 
engagement with the new module, how their knowledge 
of QI changed and investigates how the learning was 
applied in practice.
MeThods
We initially provide a description of how the collaborative 
process unfolded between the HEI/LPCs. Focus groups 
were held with pharmacists at the end of the module to 
assess the impact on pharmacist learning and behaviour.
description of the collaboration between heI/LPc
The Chief Officer (FL) representing Coventry, Warwick-
shire, Herefordshire and Worcestershire LPCs (consisting 
of approximately 333 community pharmacies) met with 
members of the School of Pharmacy (De Montfort Univer-
sity) (SG, TA and NG) in January 2019 to discuss the devel-
opment and delivery of a postgraduate QI training module 
that could upskill community pharmacists. The aim of 
this learning sought to improve the quality of community 
pharmacy services that is, to promote safety, effectiveness 
and patient experience. For research purposes, detailed 
descriptive data about the collaborative process between the 
HEI and LPC were recorded by FL and SG. This included 
keeping notes of meetings, emails, phone calls and all 
interactions and correspondence with the pharmacies and 
individual pharmacists. Funding for the QI module was via 
Health Education England (HEE) through the Pharmacy 
Integration Fund (PhIF). The PhIF is an initiative set up 
by NHS England to develop pharmacist skills and support 
the integration of community pharmacy into mainstream 
primary care practice in order to deliver better outcomes 
for patients.16
Following collaborative discussions, it was decided that 
the module would be designed to provide pharmacists with 
methodological training in the principles of QI and that the 
learning would be ‘workplace driven’. During the training, 
pharmacists would be encouraged to develop critical anal-
ysis skills and identify services they deemed to be suboptimal 
to which appropriate QI tools and methodology could be 
applied. This would place the onus on pharmacists to take 
responsibility through audit assessments in order to uncover 
areas where they felt QI would most benefit their practice 
(table 1). This was in keeping with paedagogical principles, 
specifically adult transformative learning theories (Knowles 
andragogy), where learners are said to have more say in 
the direction of learning, are able to build on their existing 
experience and engage with activities that are of perceived 
relevance.17
Once the training was developed, the LPCs took 
responsibility for advertising and inviting all community 
pharmacists within their catchment areas to undertake 
the module. It was estimated that the time commitment 
for undertaking the learning would be roughly 10 hours 
per week. This was made clear in all promotional mate-
rials and communications with pharmacists. The module 
was to be delivered over a 6- month period via an online 
virtual learning platform with three face- to- face training 
sessions (delivered by TA and supported by NG and SG). 
The recruitment target was agreed to be approximately 
20 pharmacists. It was envisaged that this number would 
allow for a close learning relationship with the module 
leader (TA) and also foster professional networking and 
peer- to- peer support.
Focus groups
Using purposive sampling, all pharmacists who had 
initially enrolled onto the module were made aware of 
the research and provided with a study information sheet 
(via email and verbally at the first face- to- face training 
session) and invited to take part in a focus group discus-
sion. Participants were informed that the purpose of the 
focus group was to explore their motivation and experi-
ence of enrolling onto the QI module, barriers and facil-
itators to learning and perceived impact (if any), of their 
learning on professional practice and patient care. Focus 
groups were employed to create active and dynamic inter-
actions between participants through which ideas and 
contrary opinions, as well as new areas of understanding, 
could be generated compared with individual interviews 
alone.18 Each focus group lasted approximately 1 hour 
and were held at a local hotel. For convenience, focus 
groups were arranged to coincide with the final face- 
to- face training session. With the participant’s written 
consent, focus groups were audio recorded with detailed 
field notes taken during and after. The topic guide can be 
found in Appendix 1.
Inclusion criteria
Eligibility criteria to participate in the focus group 
included: (1) registered pharmacist, (2) enrolled onto 
the QI postgraduate module and (3) willing, consenting 
and able to take part in the focus group.
Reflexivity
To minimise bias and avoid influencing participant 
responses, focus groups were led by two researchers who 
were not known to the participants and who did not have 
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Table 1 Details and learning outcomes of postgraduate quality improvement (QI) module
Module description QI
Delivered by Leicester School of Pharmacy (De Montfort University)
Degree level and credit Postgraduate level 7
Delivery mode Online distance learning, with tutor support and three interactive face- to- face events.
Duration Six (6) months
Indicative content/ areas of study  ► Clinical pharmacy management: health policy, healthcare organisation and 
management.
 ► Audit techniques.
 ► Clinical governance and how it relates to pharmaceutical services including training 
and auditing to drive service enhancement.
 ► Risk management, dispensing and medication errors, the causes, theory and 
investigation of medication errors.
 ► Service operation and delivery – service improvement, models of pharmacy practice, 
quality management theory and performance.
Learning outcomes  ► Critically review, using quality management methods, the provision of a chosen 
pharmaceutical service or provision.
 ► Appraise the strengths and weakness of the current service.
 ► Devise a proposal, based on critical review and appraisal, to enable the service to be 
enhanced. Assess clinical governance principles, risk management and local and/ or 
national policies and priorities relating to the service.
 ► Generate and implement SMART (specific, measurable, achievable, realistic and time- 
bound), improvements to the chosen service.
 ► Plan the assessment or reaudit of the improved service.
 ► Critically analyse operational and personal development.
Assessment  ► 3000- word report
 ► Portfolio of evidence
any involvement in the conceptualising, management or 
delivery of the QI module. One focus group was led by 
the lead author AL (male). He has a PhD in pharmacy 
practice research and extensive experience in qualitative 
methods. The second was led by a pharmacist educator 
(male).
Data analysis
All data describing the collaboration including planning, 
development and delivery of the module were collated, 
diagrammatically charted and finally narrated as activities 
primarily led by the HEI or those led by the LPC. The 
focus group discussions were transcribed verbatim and 
the data imported into the qualitative software package 
NVivo V.10.19 Using a constructivist qualitative method-
ology a thematic analysis was performed by AL which 
involved a five- stage process as described by Richards and 
Hemphill.20 21 This included (1) familiarisation with the 
data through initial reading and rereading of the tran-
scribed data and preliminary organisation. (2) Open and 
axial coding and comparison for their internal consist-
ency and boundaries. (3) Emergence of a codebook. The 
coding tree captured the main themes including codes 
relating to disconfirming cases. (4) Final coding process 
and finalising themes. (5) Synthesis and narration of the 
identified themes. To enhance the consistency of analysis, 
all the coded data and analysis were reviewed by a sepa-
rate member of the research team (NG). To enhance the 
credibility and trustworthiness of the findings, the themes 
were then discussed with all members of the research 
team.
Patient and public involvement
This study explored community pharmacist's views of a 
postgraduate QI educational module. Involving patients/
the public in the design, or conduct was not deemed 
necessary at this stage.
resuLTs
collaboration and pharmacist recruitment to the QI module
The collaborative HEI–LPC partnership was feasible and 
deemed to be a success in developing and delivering the 
QI module. The two organisations worked effectively 
together to promote the QI module including the devel-
opment of promotional materials (ie, flyers, marketing 
videos) and using social media to raise awareness. Details 
of the types of communication between the HEI and 
LPC and pharmacists are represented in table 2. Twen-
ty- one community pharmacists expressed an interest in 
undertaking the QI learning, of which 15 enrolled onto 
the module (4 pharmacists from independents, 11 from 
chain pharmacies).
Focus groups
All of the pharmacists who attended the final training 
session (total of eight community pharmacists) took 
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Table 2 Details of the collaboration and tasks assigned to the Higher Educational Institute (HEI) and Local Pharmaceutical 
Committees (LPCs)






Initial face- to- face meeting to discuss common interests, process of collaborative working including defining aims and 
objectives and how to assess outcomes of QI project.
Follow- up email/telephone calls to agree actions for HEI–LPC
HEI lead has an in- depth discussion with postgraduate team to 
assess feasibility and management of the QI project.
LPC lead configures an LPC ‘working group’ in 
order to disseminate QI project plans.






y Development of promotional materials, that is, flyers and student 
testimonials, (written and video) from other postgraduate students 
demonstrating benefits of postgraduate learning to practice.





LPC lead invites sent on a weekly basis (via email) 
to pharmacy contractors about the QI module using 
flyer and recorded student testimonial.
Promotional materials added to LPC website.
Project promoted on HEI–LPC social media (Twitter, Facebook etc.).
Weekly Skype meetings to discuss recruitment numbers and marketing of QI to pharmacies.
HEI to communicate with interested students and provide further 




ril Face- to- face promotion of QI module to community 




HEI registration information emailed to pharmacists with details of 
the first training session including the pre- session tasks.
LPC lead relays expressions of interest from 
pharmacists to HEI.
Final deadline for recruitment advertised to students.
Delivery of first QI training session. Project timeframe and plan 
agreed with pharmacists.
Dates of training sessions posted on LPC website.
 
 Ju


















er Delivery of third training session and conduct of focus group.
HEI–LPC discuss outcomes/reflections on the collaboration and provide information about the process for analysis.
QI, Quality Improvement.
part in one of two focus groups. Three participants 
were employed by an independent pharmacy and five 
from chain pharmacies (age range 32–50 years). Three 
themes emerged based around pharmacist engagement 
(including barrier to learning), pharmacist knowledge 
and application of QI and around reflective practice.
Pharmacist engagement
Pharmacists were intrigued by the LPC’s invitation to 
take part in postgraduate education (PGE). The LPC 
was viewed as a communication conduit between the 
HEI and themselves. In addition to emails, the invita-
tion was promoted at other LPC training events to raise 
awareness and encourage pharmacists to take part. The 
HEI–LPC model appeared to signal a vote of confidence 
that gave pharmacists the motivation and reassurance to 
sign up:
For me personally, if it weren’t for the LPC I 
certainly wouldn’t be engaging on this module … 
they advertised it and brought it forward. [FG1_
Female_32yrs]
A few pharmacists saw the learning as a means to complete 
their mandatory CPD or for them to extend their employ-
ability, particularly in light of younger ‘newly qualified’ 










ual: first published as 10.1136/bm




 5Latif A, et al. BMJ Open Quality 2021;10:e001047. doi:10.1136/bmjoq-2020-001047
Open access
pharmacists who were perceived to be more skilled than 
themselves:
The newly qualified pharmacists would be more 
qualified than us …With the funding cuts and 
everything, stores closing and so on, I think it’s a 
scary time. So, we just need to up our game. [FG1_
Female_34yrs]
Most however, reported a desire to acquire new skills and 
to see the application of QI learning in their practice.
Reflecting on the postgraduate learning, this had been 
an overall enjoyable experience due to the close working 
relationships and networks that had developed between 
fellow pharmacists and the HEI leads. When asked, many 
were encouraged to pursue further PGE. Of the 15 phar-
macists who enrolled onto the QI module, upon comple-
tion, 12 registered for further postgraduate modules:
If I was sitting reading my emails before bedtime 
thinking of “really? Diploma? No”, I probably 
wouldn’t have done it. [FG1_Female_34yrs]
I thought this would be a good step before I take the 
full plunge, to just try it out, before I commit to the 
full postgraduate clinical diploma. [FG2_Male_34yrs]
Barriers to learning
Embarking on the module was daunting for some phar-
macists. There was apprehension at the prospect of having 
to accommodate the new learning and potential to inter-
rupt their work–life balance. Academic writing was a new 
and challenging skill and there was a consensus that peer 
support was important:
It is hard, but I think with support and talking with 
your colleagues, it’s helped. And yeah, initially I 
thought it was going to be really challenging because 
I haven’t done anything like this since university … 
[FG2_Female_33yrs]
Regarding organisational support, pharmacists reported 
challenges negotiating time off to attend the face to face 
training sessions resulting in some resorting to using their 
annual leave entitlement or taking unpaid leave. Phar-
macists did not always feel supported and reported that 
managers were sceptical of their motives and fearful of 
losing them because of being ‘upskilled’:
They had a bit of fear that I’ll move into a GP 
surgery. And that was clear to see from a very frank 
conversation. [FG1_Female_32yrs]
There were also concerns that the analytical skills being 
taught were not aligned with employers’ expectations:
They want more of a faster snap model whereby they 
can improve quality, so if they see a problem they 
want a solution within a few days or something like 
that. [FG2_Male_45yrs]
There needs to be a little bit of vision to see we 
need pharmacists with more skills in our company 
to meet the challenges of the future profession. At 
the moment, you might not find that vision in senior 
management. [FG1_Male_39yrs]
Knowledge of QI and application in practice
Following the learning, pharmacists reported positive 
changes in pharmacy culture and practice. They had 
limited knowledge of QI tools (eg, root cause analysis) 
or applied these to their practice. They appreciated the 
value of these skills and described how they were able to 
be more analytical in their day- to- day problem solving:
One of my technicians came to me and said “we 
need to do something about these controlled drug 
prescriptions after they’ve been handed out”. I said 
“ok”. My technician went straight into the solution. 
I said “right, let me stop you there. I need you to 
define the problem”; I listened to myself and said [to 
myself] something’s sunk in. [Whereas prior to the 
module, what would you have done?] I would have 
said ‘Ok, let’s run with it’ without necessarily giving 
any thought to whether that was the best solution. 
[FG1_Male_39yrs]
If in the past there was some problem, I’ll go straight 
to the solution. With this I’ve tried to get the whole 
team involved more… and it’s brought the team 
together more and understand the problem as a 
whole. [FG1_Female_34yrs]
When asked about the impact on patient care and 
outcomes, there was a consensus that more time was 
needed to fully assess this, though it was presumed that 
an enhancement of service quality would, in the long 
term, have a positive impact. It was felt that educating and 
upskilling the pharmacy team in QI would generate more 
meaningful team conversations that would help patients. 
Pharmacists appreciated how QI strategies had enabled 
them to involve other members of the pharmacy team. 
Not only were they able to identify and provide solu-
tions where services were suboptimal, but the learning 
appeared to be cascaded to others:
I think by doing this project it’s made me feel more 
confident in leading my team, in terms of bringing 
about change or improvement in my practice, and 
they’ve [staff] also started thinking on that level as 
well. So instead of just highlighting problems they’re 
now thinking further … “ok what changes do we need 
to make, we need to have a discussion about this”, so 
that’s the sort of steps that they’re taking now in their 
thought process. [FG2_Male_37yrs]
It involved their perspective, because I think when 
we do an audit we tell them this is what is done. 
Whereas with the [QI] tools, they were actually 
engaging the staff themselves to do it which I felt was 
good, and they contributed more personally. [FG2_
Female_38yrs]
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One pharmacist acquired sufficient confidence to discuss 
improvement ideas with wider organisational stake-
holders to influence service development:
I spoke to service development pharmacists … 
because we’re looking at different things …I wouldn’t 
have done that before I’d done this project. I wouldn’t 
have really focused in on those areas to support my 
idea. [FG1_Female_32yrs]
In contrast to those regularly working in one pharmacy, 
relief pharmacists (who worked in several pharmacies) 
found it arduous and challenging to apply their learning 
with staff who they were not routinely working with.
The reflective practitioner
There was evidence that the postgraduate QI module 
had developed pharmacists to be more reflective in their 
practice. This was attributed to the type of learning they 
engaged with, which was seen to be different from the 
previous self- directed CPD they had undertaken. Most 
considered PGE to be superior to self- directed CPD 
because of the benefits of peer learning and having 
specialist input from the HEI.
This is completely different to what I’ve ever learnt 
in any other form of CPD, whether its employer led, 
or LPC led, or everything, it’s been different. [FG1_
Female_34yrs]
Pharmacists reported having an appreciation of the 
learning process and greater awareness that learning 
should impact on practice and their personal develop-
ment. Taking part in the module had prompted one phar-
macist to reflect on how he could improve the quality of 
his future role as an independent prescriber:
My only goal was to become an IP [Independent 
Prescriber]… I would say my goal changed to 
becoming a really good IP. So, going through the 
modules, the diploma, and then having an IP at the 
end of it, I think will make you a better practitioner 
than someone who’s just gone and done a 6- month 
course. [FG1_Male_39yrs]
dIscussIon
This illustrative case study showed that collaborative part-
nerships between HEIs and LPCs organisations are feasible 
and that a postgraduate module can improve pharmacist 
engagement with QI. This collaborative model signalled 
a vote of confidence that gave pharmacists reassurance 
to sign up to the module. Despite the benefits of PGE to 
clinical practice, studies show the uptake of PGE among 
pharmacists, as with other professionals, remains low.22 
Others have also identified barriers including a perceived 
lack of time or resource and organisational constraints.23 
Despite the barriers, there were benefits of learning with 
peers, which is often a drawback identified by CPD that 
is undertaken in silos.24 25 There was also evidence that 
the QI module had encouraged ‘reflective practice’ or as 
described by Mann as “the purposeful critical analysis of 
knowledge and experience, in order to achieve deeper 
meaning and understanding”.26
It has long been acknowledged that professionals learn 
more from practice than theory alone.27 The evidence 
regarding the most effective pedagogical approaches to 
improve QI training is mixed, with didactic classroom 
learning less likely to be effective compared with work-
place driven QI practices.28 29 This study supports the 
work- based driven approach and found that pharma-
cists’ perceptions and experience of the QI learning was 
positive with reports of the application of QI principles 
in practice. Experience of effective and relevant PGE, in 
the absence of perceived barriers, has shown to enhance 
clinical decision- making and career development, inter-
professional working and improvements in patient care.30 
It has also been shown to be the case in other professions 
where introducing QI learning has been shown to develop 
skills, understanding and to foster a positive attitude 
which has the ability to influence clinical practice.31–33
strengths, limitations and implications
To our knowledge this is the only UK study that describes 
LPCs working collaboratively with an HEI to promote QI 
learning among community pharmacists. We acknowledge 
several limitations to this study. This was a small scale illus-
trative case study. There were 15 pharmacists who completed 
the training and so the views expressed may not be repre-
sentative of all pharmacists, but rather those who may have 
been more keen or motivated to engage or who could be 
described as ‘early adopters’. In addition, only 8/15 phar-
macists participated in the focus group and so the findings 
should be viewed with caution as it is uncertain whether data 
saturation was reached. The wide geographical area some 
pharmacists would have had to travel for the face- to- face 
training sessions, may explain in part why more pharmacists 
chose not to attend. In regards to the transferability of the 
findings to other settings, we acknowledge the risk of bias in 
our study. This was an illustrative case study and do not know 
whether this collaborative model would work in other settings 
where the working relationship between the HEI/LPC could 
be different. Furthermore we are unable to validate findings 
from self- reports or make generalised claims at this stage.
It is also unknown how the QI training had impacted on 
service quality or patient outcomes in the long term. This is 
similar to the findings of others. For instance, a QI interven-
tion study in the USA found that after a follow- up period of 2 
months, investigators were unable to detect the impact either 
on quality related events or patient safety attitudes.34 The 
impact of a QI learning intervention appear therefore to take 
time to imbed in practice and that any assessment of patient- 
related outcomes should acknowledge that outcomes are 
likely to be gradual or incremental. Others have suggested 
that regular repetition of QI messages are needed to sustain 
improvements in practice.35
This initiative was funded by HEE who supported fees for 
pharmacist’s enrolment onto the QI module. The results of 
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this study and another evaluation36 suggest that the learning 
has potential to improve community pharmacy service 
quality and upskill pharmacists in application of QI methods. 
Professional bodies should consider further investment to 
ensure the QI module can be offered in a sustainable way. 
The success of the module has led to this now being offered 
from De Montfort University and has been integrated into 
students postgraduate clinical qualifications.
We complete this paper at a time when healthcare 
systems are in a process of significant transformation in 
the organisation and delivery of healthcare due to the 
COVID-19 pandemic. Policy- makers have made rapid 
changes to reorganise care services to meet the surge in 
demand of patients with COVID-19, including profes-
sional reprofiling and creating new care pathways. Along-
side these sweeping changes, there have been reforms 
to UK community pharmacy contractual arrangements 
towards and integrated care systems providing extended 
clinical services.37–39 There are increased expectations 
on community pharmacy to help reduce the burden 
on other areas of the healthcare system, particularly in 
general practice.39 These reforms and recent changes in 
practice have led to unprecedented changes as front line 
services become refashioned with significant day- to- day 
practice implications for service delivery and gover-
nance. It is yet unclear how pharmacists are responding 
to such service reconfiguration or how these changes are 
impacting on the quality of services delivered. If appro-
priate support or training is not realised, pharmacist risk 
‘role overload’ or ‘role strain’ that can contribute to poor 
quality of services to patients.40 This research is timely; 
there is a pressing need to promote QI within commu-
nity pharmacy to provide assurance that pharmacist and 
their teams are equipped with the knowledge and skills to 
maintain patient safety and care.
concLusIons
This study illustrates that a HEI–LPC collaboration is 
feasible and able to engage and upskill community phar-
macists through a postgraduate QI module. Despite the 
barriers to learning, pharmacist demonstrated improved 
knowledge and application of QI methods and reported 
using these approaches with their teams to improve prac-
tice. With the increased adoption of new pharmacist’s 
roles and services, promoting QI training should be a 
priority for policy- makers if service quality is to be main-
tained in a dynamic and complex healthcare system.
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Appendix 1 Focus group topic guide  
Welcome, introductions and consent 
Reasons for undertaking the module  
 How did you hear about the course? 
 What motivated you to register? 
 What were your thoughts and feelings as you embark upon this course? 
 
Role of the LPCs  
 What communication, if any, did you have with the LPC and did this influence your 
decision to take the QI module? 
 Would you have undertook the QI module if the LPC had not been involved? 
 
Experience of the module and impact on practice (if any) 
 Discuss barriers and facilitators to undertaking postgraduate training 
 What did you learn and how has it impacted on your practice? 
 In what ways, if any, has this improved patient care?  
 
Thank participants for their time.  
 
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open Qual
 doi: 10.1136/bmjoq-2020-001047:e001047. 10 2021;BMJ Open Qual, et al. Latif A
